SEC Form 4 · accession 0000919574-18-002552
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Broadfin Healthcare Master Fund Ltd
Director · 10% Owner
Broadfin Capital, LLC
Director · 10% Owner
Kevin Kotler
Director · 10% Owner
Period of report
Mar 15, 2018
Accepted (ET)
Mar 19, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF2,F1 | $4.40 | Mar 15, 2018 | A | 909,296 | A | — | Mar 16, 2022 | Common Shares | 909,296 | 909,296 | D |
Explanation of responses
- F1The Warrants are exercisable at the option of the Reporting Persons at any time prior to March 16, 2022; provided, however, that the Warrants are subject to a limitation in the Warrant instrument on the exercise of the Warrants to the extent that such exercise would cause the Reporting Persons to beneficially own more than 9.99% of the Issuer's common stock.
- F2The Warrants are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.